Selected article for: "mortality severity and risk factor"
Author: Norouzi, Mahnaz; Norouzi, Shaghayegh; Ruggiero, Alistaire; Khan, Mohammad S.; Myers, Stephen; Kavanagh, Kylie; Vemuri, Ravichandra
Title: Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection
  • Cord-id: asnz0c61
  • Document date: 2021_6_3
    • ID: asnz0c61
    Snippet: The current outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), termed coronavirus disease 2019 (COVID-19), has generated a notable challenge for diabetic patients. Overall, people with diabetes have a higher risk of developing different infectious diseases and demonstrate increased mortality. Type 2 diabetes mellitus (T2DM) is a significant risk factor for COVID-19 progression and its severity, poor prognosis, and increased mortality. How diabetes contributes to COV
    Document: The current outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), termed coronavirus disease 2019 (COVID-19), has generated a notable challenge for diabetic patients. Overall, people with diabetes have a higher risk of developing different infectious diseases and demonstrate increased mortality. Type 2 diabetes mellitus (T2DM) is a significant risk factor for COVID-19 progression and its severity, poor prognosis, and increased mortality. How diabetes contributes to COVID-19 severity is unclear; however, it may be correlated with the effects of hyperglycemia on systemic inflammatory responses and immune system dysfunction. Using the envelope spike glycoprotein SARS-CoV-2, COVID-19 binds to angiotensin-converting enzyme 2 (ACE2) receptors, a key protein expressed in metabolic organs and tissues such as pancreatic islets. Therefore, it has been suggested that diabetic patients are more susceptible to severe SARS-CoV-2 infections, as glucose metabolism impairments complicate the pathophysiology of COVID-19 disease in these patients. In this review, we provide insight into the COVID-19 disease complications relevant to diabetes and try to focus on the present data and growing concepts surrounding SARS-CoV-2 infections in T2DM patients.

    Search related documents:
    Co phrase search for related documents
    • activity level and acute respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • activity level and acute respiratory distress syndrome: 1
    • activity level and acute respiratory syndrome sars: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
    • activity level and liver damage: 1, 2
    • activity level and long term immunity: 1
    • activity level and lung injury: 1, 2, 3, 4
    • acute phase protein and liver damage: 1, 2
    • acute phase protein and lung injury: 1, 2, 3
    • acute respiratory disease and adipocyte hypertrophy: 1
    • liver damage and lung ards injury: 1
    • liver damage and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • liver damage and lymphopenia interleukin: 1
    • liver damage and macrophage protein: 1, 2, 3
    • liver damage and macrophage recruitment: 1
    • liver dysfunction and low respiratory tract: 1
    • liver dysfunction and lung injury: 1, 2, 3, 4, 5, 6
    • low respiratory tract and lung ards injury: 1
    • low respiratory tract and lung injury: 1